How can true supply chain agility be achieved in response to increasingly complex trial demands?
This question will be explored at the upcoming Clinical Trial Supply Europe 2024 conference, held on 6-7 April in Barcelona, Spain, where pharmaceutical companies and biotech’s will discuss and debate new technologies and processes aimed at streamlining supply chain operations, over the course of two days.
Day one of CTS Europe will open with a keynote about the healthcare transition into a Net Zero world, followed by presentations from industry players including Sanofi, on building an agile and resilient end-to-end supply chain. Experts will discuss how to enhance global supply chain security by improving quality processes and leveraging technologies.
After mid-morning, the conference will be split into two streams, with the opportunity to focus on either clinical supply logistics and operations, or technology and innovation. The two streams continue throughout both days of the conference.
The clinical supply logistics and operations stream explores how to optimise and overcome supply chain challenges, focusing on improving sustainability and meeting the future expectations of patients in clinical trials. The technology and innovation stream will explore emerging technologies such as blockchain, as well as taking a deep dive into the role of tech in streamlining cell and gene therapy logistics.
The second day of the conference includes panel discussions and presentations on topics such as risk management in supply chains, direct-to-patient business services, lessons learned in setting up clinical trials and innovative solutions for complex trial supply chains.
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
Additionally, two experts from the US Customs and Border Protection (CBP) will explain the significance of navigating multiple regulatory agencies to help expedite supply chain times, such as understanding the requirement and options for declaring biological materials to CBP.
Day two concludes with five roundtable discussions tackling diverse challenges in clinical trial supply. There will be an option of two topics, led by a moderator focusing on specific issues. Delegates select their preferred topic and can swap tables after 60 minutes, with each roundtable running twice.
